The company’s CEO said it was on track to achieve this at COP27

They are partnering through a taskforce launched at COP26 last year, which aims to tackle emissions across patient care, clinical trials and supply chains

A propellant that has up to 99.9% less global warming potential than those currently used in respiratory medicines will be used